Cargando…

Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis

Cerebral venous thrombosis (CVT) is a long-term debilitating vascular brain disease with high morbidity and mortality. It may be associated with rise in D-dimer level. The aim of this study was to examine this potential association and identify the critical D-dimer cut-off level corresponding to inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashami, Leila, Rakhshan, Vahid, Karimian, Hoda, Moghaddasi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935813/
https://www.ncbi.nlm.nih.gov/pubmed/27441064
http://dx.doi.org/10.4081/ni.2016.6310
_version_ 1782441460405108736
author Hashami, Leila
Rakhshan, Vahid
Karimian, Hoda
Moghaddasi, Mehdi
author_facet Hashami, Leila
Rakhshan, Vahid
Karimian, Hoda
Moghaddasi, Mehdi
author_sort Hashami, Leila
collection PubMed
description Cerebral venous thrombosis (CVT) is a long-term debilitating vascular brain disease with high morbidity and mortality. It may be associated with rise in D-dimer level. The aim of this study was to examine this potential association and identify the critical D-dimer cut-off level corresponding to increase the risk of CVT. This case-control study was conducted on two groups of patients with and without CVT attending the Rasool Akram Hospital (Iran) during 2014 and 2015. D-dimer levels were measured by the rapid sensitive D-dimer assay. Data were analyzed by Spearman’s correlation coefficient test, independent-samples t-test, backward-selection multiple linear regression and multiple binary logistic regression analyses. Sensitivity-specificity tests were used to detect D-dimer cut-off for CVT. Differences between the D-dimer levels of the case and control groups were significant (P<0.001). It showed that each level of increase in the number of symptoms could increase the risk of thrombosis occurrence for about 3.5 times. All symptom types except for headache were associated with D-dimer level, while headache has negative association with D-dimer level. D-dimer cut-off point for CVT diagnosis was estimated at 350 ng/mg. We concluded that D-dimer serum level significantly rises in CVT patients. A rounded cut-off point of 350 ng/mg can be used as a diagnostic criterion for CVT prediction.
format Online
Article
Text
id pubmed-4935813
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-49358132016-07-20 Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis Hashami, Leila Rakhshan, Vahid Karimian, Hoda Moghaddasi, Mehdi Neurol Int Article Cerebral venous thrombosis (CVT) is a long-term debilitating vascular brain disease with high morbidity and mortality. It may be associated with rise in D-dimer level. The aim of this study was to examine this potential association and identify the critical D-dimer cut-off level corresponding to increase the risk of CVT. This case-control study was conducted on two groups of patients with and without CVT attending the Rasool Akram Hospital (Iran) during 2014 and 2015. D-dimer levels were measured by the rapid sensitive D-dimer assay. Data were analyzed by Spearman’s correlation coefficient test, independent-samples t-test, backward-selection multiple linear regression and multiple binary logistic regression analyses. Sensitivity-specificity tests were used to detect D-dimer cut-off for CVT. Differences between the D-dimer levels of the case and control groups were significant (P<0.001). It showed that each level of increase in the number of symptoms could increase the risk of thrombosis occurrence for about 3.5 times. All symptom types except for headache were associated with D-dimer level, while headache has negative association with D-dimer level. D-dimer cut-off point for CVT diagnosis was estimated at 350 ng/mg. We concluded that D-dimer serum level significantly rises in CVT patients. A rounded cut-off point of 350 ng/mg can be used as a diagnostic criterion for CVT prediction. PAGEPress Publications, Pavia, Italy 2016-06-15 /pmc/articles/PMC4935813/ /pubmed/27441064 http://dx.doi.org/10.4081/ni.2016.6310 Text en ©Copyright L. Hashami et al. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Hashami, Leila
Rakhshan, Vahid
Karimian, Hoda
Moghaddasi, Mehdi
Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title_full Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title_fullStr Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title_full_unstemmed Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title_short Diagnostic Value of D-Dimer’s Serum Level in Iranian Patients with Cerebral Venous Thrombosis
title_sort diagnostic value of d-dimer’s serum level in iranian patients with cerebral venous thrombosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935813/
https://www.ncbi.nlm.nih.gov/pubmed/27441064
http://dx.doi.org/10.4081/ni.2016.6310
work_keys_str_mv AT hashamileila diagnosticvalueofddimersserumleveliniranianpatientswithcerebralvenousthrombosis
AT rakhshanvahid diagnosticvalueofddimersserumleveliniranianpatientswithcerebralvenousthrombosis
AT karimianhoda diagnosticvalueofddimersserumleveliniranianpatientswithcerebralvenousthrombosis
AT moghaddasimehdi diagnosticvalueofddimersserumleveliniranianpatientswithcerebralvenousthrombosis